ClinicalTrials.Veeva

Menu

Antimicrobial Pulpotomy of Primary Molars

U

Universidade Federal de Goias

Status and phase

Completed
Phase 4

Conditions

Inflammation
Necrosis

Treatments

Procedure: Antimicrobial pulpotomy
Procedure: Calcium hydroxide pulpectomy

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

There is a lack of evidence of the long-term successful outcomes of antimicrobial endodontic treatment for primary teeth. This study intended to evaluate (by survival analysis) the effectiveness of an antimicrobial pulpotomy (chloramphenicol, tetracycline, zinc oxide/eugenol) in primary molars compared to calcium hydroxide pulpectomy, testing the hypothesis that antimicrobial pulpotomy could be an alternative pulp therapy for primary teeth with pulp inflammation or necrosis.

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy children (ASA PS 1)
  • Children presenting one or more primary molar with pulp inflammation or necrosis due to carious lesion and indicated for endodontic therapy

Exclusion criteria

  • Lost to follow-up

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

0 participants in 2 patient groups

Antimicrobial pulpotomy
Experimental group
Description:
Pulpotomy of primary molars with pulp inflammation or necrosis due to carious lesions using an antimicrobial paste
Treatment:
Procedure: Antimicrobial pulpotomy
Calcium hydroxide pulpectomy
Active Comparator group
Description:
Pulpectomy of primary molars with pulp inflammation or necrosis due to carious lesions using a calcium hydroxide paste as intracanal medication
Treatment:
Procedure: Calcium hydroxide pulpectomy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems